» Articles » PMID: 34451874

Mechanistic Insight into the Effects of Curcumin on Neuroinflammation-Driven Chronic Pain

Overview
Publisher MDPI
Specialty Chemistry
Date 2021 Aug 28
PMID 34451874
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic pain is a persistent and unremitting condition that has immense effects on patients' quality of life. Studies have shown that neuroinflammation is associated with the induction and progression of chronic pain. The activation of microglia and astrocytes is the major hallmark of spinal neuroinflammation leading to neuronal excitability in the projection neurons. Excessive activation of microglia and astrocytes is one of the major contributing factors to the exacerbation of pain. However, the current chronic pain treatments, mainly by targeting the neuronal cells, remain ineffective and unable to meet the patients' needs. Curcumin, a natural plant product found in the Curcuma genus, improves chronic pain by diminishing the release of inflammatory mediators from the spinal glia. This review details the role of curcumin in microglia and astrocytes both in vitro and in vivo and how it improves pain. We also describe the mechanism of curcumin by highlighting the major glia-mediated cascades in pain. Moreover, the role of curcumin on inflammasome and epigenetic regulation is discussed. Furthermore, we discuss the strategies used to improve the efficacy of curcumin. This review illustrates that curcumin modulating microglia and astrocytes could assure the treatment of chronic pain by suppressing spinal neuroinflammation.

Citing Articles

Phytochemical-based therapeutics from traditional eastern medicine: analgesic effects and ion channel modulation.

Kim S, Chung G, Kim S Front Pain Res (Lausanne). 2025; 6:1537154.

PMID: 39958366 PMC: 11825757. DOI: 10.3389/fpain.2025.1537154.


New phenanthrenequinones from roots and their anti-inflammatory activity on lipopolysaccharide-activated BV2 microglial cells.

Thant M, Hasriadi H, Poldorn P, Jungsuttiwong S, Rojsitthisak P, Bottcher C RSC Adv. 2024; 14(39):28390-28400.

PMID: 39239286 PMC: 11375963. DOI: 10.1039/d4ra04761c.


Role of Curcuma longae Rhizoma in medical applications: research challenges and opportunities.

Zhang P, Liu H, Yu Y, Peng S, Zhu S Front Pharmacol. 2024; 15:1430284.

PMID: 39170702 PMC: 11336575. DOI: 10.3389/fphar.2024.1430284.


Neuronutritional Approach to Fibromyalgia Management: A Narrative Review.

Badaeva A, Danilov A, Kosareva A, Lepshina M, Novikov V, Vorobyeva Y Pain Ther. 2024; 13(5):1047-1061.

PMID: 39042252 PMC: 11393252. DOI: 10.1007/s40122-024-00641-2.


Impact of curcumin supplementation on exercise performance and muscle damage after a soccer match: a double-blind placebo-controlled cross-over study.

Tanabe Y, Kondo E, Sagayama H, Shimizu K, Yasumatsu M, Nakamura D Eur J Appl Physiol. 2024; 124(7):2161-2170.

PMID: 38436665 DOI: 10.1007/s00421-024-05429-y.


References
1.
Belcaro G, Dugall M, Luzzi R, Ledda A, Pellegrini L, Cesarone M . Meriva®+Glucosamine versus Condroitin+Glucosamine in patients with knee osteoarthritis: an observational study. Eur Rev Med Pharmacol Sci. 2015; 18(24):3959-63. View

2.
Schiborr C, Kocher A, Behnam D, Jandasek J, Toelstede S, Frank J . The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol Nutr Food Res. 2014; 58(3):516-27. DOI: 10.1002/mnfr.201300724. View

3.
Wang Z, Ren W, Zhao F, Han Y, Liu C, Jia K . Curcumin amends Ca dysregulation in microglia by suppressing the activation of P2X7 receptor. Mol Cell Biochem. 2020; 465(1-2):65-73. DOI: 10.1007/s11010-019-03668-8. View

4.
Sofroniew M, Vinters H . Astrocytes: biology and pathology. Acta Neuropathol. 2009; 119(1):7-35. PMC: 2799634. DOI: 10.1007/s00401-009-0619-8. View

5.
Yu Y, Shen Q, Lai Y, Park S, Ou X, Lin D . Anti-inflammatory Effects of Curcumin in Microglial Cells. Front Pharmacol. 2018; 9:386. PMC: 5922181. DOI: 10.3389/fphar.2018.00386. View